TY - JOUR AU - Jemal, A. AU - Center, M. M. AU - DeSantis, C. AU - Ward, E. M. PY - 2010 DA - 2010// TI - Global patterns of cancer incidence and mortality rates and trends JO - Cancer Epidemiol Biomarkers Prev VL - 19 UR - https://doi.org/10.1158/1055-9965.EPI-10-0437 DO - 10.1158/1055-9965.EPI-10-0437 ID - Jemal2010 ER - TY - JOUR AU - Siegel, R. AU - Naishadham, D. AU - Jemal, A. PY - 2013 DA - 2013// TI - Cancer statistics, 2013 JO - CA Cancer J Clin VL - 63 UR - https://doi.org/10.3322/caac.21166 DO - 10.3322/caac.21166 ID - Siegel2013 ER - TY - JOUR AU - Gooren, L. PY - 2003 DA - 2003// TI - Androgen deficiency in the aging male: benefits and risks of androgen supplementation JO - J Steroid Biochem Mol Biol VL - 85 UR - https://doi.org/10.1016/S0960-0760(03)00206-1 DO - 10.1016/S0960-0760(03)00206-1 ID - Gooren2003 ER - TY - JOUR AU - Bosch, J. L. AU - Hop, W. C. AU - Kirkels, W. J. AU - Shröder, F. H. PY - 1995 DA - 1995// TI - Natural history of benign prostatic hyperplasia: appropriate case definition and estimation of its prevalence in the community JO - Urology VL - 46 UR - https://doi.org/10.1016/S0090-4295(99)80248-9 DO - 10.1016/S0090-4295(99)80248-9 ID - Bosch1995 ER - TY - JOUR AU - Guess, H. A. PY - 1995 DA - 1995// TI - Epidemiology and natural history of benign prostatic hyperplasia JO - The Urol Clin North Am VL - 22 ID - Guess1995 ER - TY - JOUR AU - Abrams, P. PY - 1994 DA - 1994// TI - New words for old: lower urinary tract symptoms for “prostatism” JO - BMJ VL - 308 UR - https://doi.org/10.1136/bmj.308.6934.929 DO - 10.1136/bmj.308.6934.929 ID - Abrams1994 ER - TY - JOUR AU - Eckhardt, M. D. AU - Venrooij, G. E. AU - Melick, H. H. AU - Boon, T. A. PY - 2001 DA - 2001// TI - Prevalence and bothersomeness of lower urinary tract symptoms in benign prostatic hyperplasia and their impact on well-being JO - J Urol VL - 166 UR - https://doi.org/10.1016/S0022-5347(05)65985-X DO - 10.1016/S0022-5347(05)65985-X ID - Eckhardt2001 ER - TY - JOUR AU - Siegel, R. AU - DeSantis, C. AU - Virgo, K. AU - Stein, K. AU - Mariotto, A. AU - Smith, T. PY - 2012 DA - 2012// TI - Cancer treatment and survivorship statistics, 2012 JO - CA Cancer J Clin VL - 62 UR - https://doi.org/10.3322/caac.21149 DO - 10.3322/caac.21149 ID - Siegel2012 ER - TY - JOUR AU - Pandha, H. AU - Sorensen, K. D. AU - Orntoft, T. F. AU - Langley, S. AU - Hoyer, S. AU - Borre, M. PY - 2012 DA - 2012// TI - Urinary engrailed-2 (EN2) levels predict tumour volume in men undergoing radical prostatectomy for prostate cancer JO - BJU Int VL - 110 UR - https://doi.org/10.1111/j.1464-410X.2012.11208.x DO - 10.1111/j.1464-410X.2012.11208.x ID - Pandha2012 ER - TY - JOUR AU - Mazzucchelli, R. AU - Colanzi, P. AU - Pomante, R. AU - Muzzonigro, G. AU - Montironi, R. PY - 2000 DA - 2000// TI - Prostate tissue and serum markers JO - Adv Clin Path VL - 4 ID - Mazzucchelli2000 ER - TY - JOUR AU - Thompson, I. M. AU - Pauler, D. K. AU - Goodman, P. J. AU - Tangen, C. M. AU - Lucia, M. S. AU - Parnes, H. L. PY - 2004 DA - 2004// TI - Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter JO - N Engl J Med VL - 350 UR - https://doi.org/10.1056/NEJMoa031918 DO - 10.1056/NEJMoa031918 ID - Thompson2004 ER - TY - JOUR AU - Catalona, W. J. AU - Richie, J. P. AU - Ahmann, F. R. AU - Hudson, J. A. AU - Scardino, P. T. AU - Flanigan, R. C. PY - 1994 DA - 1994// TI - Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6630 men JO - J Urol VL - 151 ID - Catalona1994 ER - TY - JOUR AU - Coley, C. M. AU - Barry, M. J. AU - Fleming, C. AU - Mulley, A. G. PY - 1997 DA - 1997// TI - Early detection of prostate cancer. Part1: Prior probability and effectiveness of tests. The American College of Physicians JO - Ann Intern Med VL - 126 UR - https://doi.org/10.7326/0003-4819-126-5-199703010-00010 DO - 10.7326/0003-4819-126-5-199703010-00010 ID - Coley1997 ER - TY - JOUR AU - Andriole, G. L. AU - Crawford, E. D. AU - Grubb, R. L. AU - Buys, S. S. AU - Chia, D. AU - Church, T. R. PY - 2009 DA - 2009// TI - Mortality results from a randomized prostate-cancer screening trial JO - New Eng J Med VL - 360 UR - https://doi.org/10.1056/NEJMoa0810696 DO - 10.1056/NEJMoa0810696 ID - Andriole2009 ER - TY - JOUR AU - Basch, E. AU - Oliver, T. K. AU - Vickers, A. AU - Thompson, I. AU - Kantoff, P. AU - Parnes, H. PY - 2012 DA - 2012// TI - Screening for prostate cancer with prostate-specific antigen testing: American Society of Clinical Oncology Provisional Clinical Opinion JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2012.43.3441 DO - 10.1200/JCO.2012.43.3441 ID - Basch2012 ER - TY - JOUR AU - Greene, K. L. AU - Albertsen, P. C. AU - Babaian, R. J. AU - Carter, H. B. AU - Gann, P. H. AU - Han, M. PY - 2009 DA - 2009// TI - Prostate specific antigen best practice statement: 2009 update JO - J Urol VL - 182 UR - https://doi.org/10.1016/j.juro.2009.07.093 DO - 10.1016/j.juro.2009.07.093 ID - Greene2009 ER - TY - STD TI - U.S. Preventive Services Task Force recommendation statement. Screening for Prostate Cancer [http://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/prostate-cancer-screening]. UR - http://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/prostate-cancer-screening ID - ref17 ER - TY - JOUR AU - Yang, C. C. AU - Sun, S. S. AU - Lin, C. Y. AU - Chuang, F. J. AU - Kao, C. H. PY - 2003 DA - 2003// TI - Differentiation of prostate cancer and benign prostatic hyperplasia: the clinical value of 201Tl SPECT a pilot study JO - Ann Nuc Med VL - 17 UR - https://doi.org/10.1007/BF03006663 DO - 10.1007/BF03006663 ID - Yang2003 ER - TY - JOUR AU - Pal, R. P. AU - Maitra, N. U. AU - Mellon, J. K. AU - Khan, M. A. PY - 2013 DA - 2013// TI - Defining prostate cancer risk before prostate biopsy JO - Urol Oncol VL - 31 UR - https://doi.org/10.1016/j.urolonc.2012.05.012 DO - 10.1016/j.urolonc.2012.05.012 ID - Pal2013 ER - TY - JOUR AU - Jamaspishvili, T. AU - Kral, M. AU - Khomeriki, I. AU - Student, V. AU - Kolar, Z. AU - Bouchal, J. PY - 2010 DA - 2010// TI - Urine markers in monitoring for prostate cancer JO - Prostate Cancer Prostatic Dis VL - 13 UR - https://doi.org/10.1038/pcan.2009.31 DO - 10.1038/pcan.2009.31 ID - Jamaspishvili2010 ER - TY - JOUR AU - Moses, M. A. AU - Wiederschain, D. AU - Loughlin, K. R. AU - Zurakowski, D. AU - Lamb, C. C. AU - Freeman, M. R. PY - 1998 DA - 1998// TI - Increased incidence of matrix metalloproteinases in urine of cancer patients JO - Cancer Res VL - 58 ID - Moses1998 ER - TY - JOUR AU - Afkarian, M. AU - Bhasin, M. AU - Dillon, S. T. AU - Guerrero, M. C. AU - Nelson, R. G. AU - Knowler, W. C. PY - 2010 DA - 2010// TI - Optimizing a proteomics platform for urine biomarker discovery JO - Mol Cell Proteomics VL - 9 UR - https://doi.org/10.1074/mcp.M110.000992 DO - 10.1074/mcp.M110.000992 ID - Afkarian2010 ER - TY - JOUR AU - Shilov, I. V. AU - Seymour, S. L. AU - Patel, A. A. AU - Loboda, A. AU - Tang, W. H. AU - Keating, S. P. PY - 2007 DA - 2007// TI - The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra JO - Mol Cell Proteomics VL - 6 UR - https://doi.org/10.1074/mcp.T600050-MCP200 DO - 10.1074/mcp.T600050-MCP200 ID - Shilov2007 ER - TY - JOUR AU - Roy, R. AU - Louis, G. AU - Loughlin, K. R. AU - Wiederschain, D. AU - Kilroy, S. M. AU - Lamb, C. C. PY - 2008 DA - 2008// TI - Tumor-specific urinary matrix metalloproteinase fingerprinting: identification of high molecular weight urinary matrix metalloproteinase species JO - Clin Cancer Res VL - 14 UR - https://doi.org/10.1158/1078-0432.CCR-08-1136 DO - 10.1158/1078-0432.CCR-08-1136 ID - Roy2008 ER - TY - JOUR AU - Lin, C. Y. AU - Chin, C. H. AU - Wu, H. H. AU - Chen, S. H. AU - Ho, C. W. AU - Ko, M. T. PY - 2008 DA - 2008// TI - Hubba: hub objects analyzer a framework of interactome hubs identification for network biology JO - Nucleic Acids Res VL - 36 UR - https://doi.org/10.1093/nar/gkn257 DO - 10.1093/nar/gkn257 ID - Lin2008 ER - TY - JOUR AU - Faraggi, D. AU - Reiser, B. PY - 2002 DA - 2002// TI - Estimation of the area under the ROC curve JO - Stat Med VL - 21 UR - https://doi.org/10.1002/sim.1228 DO - 10.1002/sim.1228 ID - Faraggi2002 ER - TY - JOUR AU - Zurakowski, D. AU - Johnson, V. M. AU - Lee, E. Y. PY - 2013 DA - 2013// TI - Biostatistics in clinical decision making for cardiothoracic radiologists JO - J Thorac Imaging VL - 28 UR - https://doi.org/10.1097/RTI.0b013e318281db88 DO - 10.1097/RTI.0b013e318281db88 ID - Zurakowski2013 ER - TY - JOUR AU - DeLong, E. R. AU - Delong, D. M. AU - Clarke-Pearson, D. L. PY - 1988 DA - 1988// TI - Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach JO - Biometrics VL - 44 UR - https://doi.org/10.2307/2531595 DO - 10.2307/2531595 ID - DeLong1988 ER - TY - JOUR AU - McShane, L. M. AU - Altman, D. G. AU - Sauerbrei, W. AU - Taube, S. E. AU - Gion, M. AU - Clark, G. M. PY - 2005 DA - 2005// TI - Reporting recommendations for tumor marker prognostic studies JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2004.01.0454 DO - 10.1200/JCO.2004.01.0454 ID - McShane2005 ER - TY - JOUR AU - Rigau, M. AU - Olivan, M. AU - Garcia, M. AU - Sequeiros, T. AU - Montes, M. AU - Colás, E. PY - 2013 DA - 2013// TI - The present and future of prostate cancer urine biomarkers JO - Int J Mol Sci VL - 14 UR - https://doi.org/10.3390/ijms140612620 DO - 10.3390/ijms140612620 ID - Rigau2013 ER - TY - CHAP AU - Roy, R. AU - Coticchia, C. C. AU - Yang, J. AU - Moses, M. A. ED - Vidaya, V. ED - Bonventre, J. PY - 2010 DA - 2010// TI - Biomarkers in Cancer Biology BT - Biomarkers of Toxicity: A New Era in Medicine PB - John Wiley and Sons CY - New York UR - https://doi.org/10.1002/9780470918562.ch14 DO - 10.1002/9780470918562.ch14 ID - Roy2010 ER - TY - JOUR AU - Haj-Ahmad, T. A. AU - Abdalla, M. A. AU - Haj-Ahmad, Y. PY - 2014 DA - 2014// TI - Potential Urinary Protein Biomarker Candidates for the Accurate Detection of Prostate Cancer among Benign Prostatic Hyperplasia Patients JO - J Cancer VL - 5 UR - https://doi.org/10.7150/jca.6890 DO - 10.7150/jca.6890 ID - Haj-Ahmad2014 ER - TY - JOUR AU - Hollingsworth, M. A. AU - Swanson, B. J. PY - 2004 DA - 2004// TI - Mucins in cancer: protection and control of the cell surface JO - Nat Rev Cancer VL - 4 UR - https://doi.org/10.1038/nrc1251 DO - 10.1038/nrc1251 ID - Hollingsworth2004 ER - TY - JOUR AU - Thathiah, A. AU - Blobel, C. P. AU - Carson, D. D. PY - 2003 DA - 2003// TI - Tumor necrosis factor-alpha converting enzyme/ADAM 17 mediates MUC1 shedding JO - J Biol Chem VL - 278 UR - https://doi.org/10.1074/jbc.M208326200 DO - 10.1074/jbc.M208326200 ID - Thathiah2003 ER - TY - JOUR AU - Thathiah, A. AU - Carson, D. D. PY - 2004 DA - 2004// TI - MT1-MMP mediates MUC1 shedding independent of TACE/ADAM17 JO - Biochem J VL - 382 UR - https://doi.org/10.1042/BJ20040513 DO - 10.1042/BJ20040513 ID - Thathiah2004 ER - TY - JOUR AU - Arul, G. S. AU - Moorghen, M. AU - Myerscough, N. PY - 2000 DA - 2000// TI - Mucin gene expression in Barrett’s oesophagus: an in situ hybridisation and immunohistochemical study JO - Gut VL - 47 UR - https://doi.org/10.1136/gut.47.6.753 DO - 10.1136/gut.47.6.753 ID - Arul2000 ER - TY - JOUR AU - Wang, R. Q. AU - Fang, D. C. PY - 2003 DA - 2003// TI - Alterations of MUC1 and MUC3 expression in gastric carcinoma: relevance to patient clinicopathological features JO - J Clin Pathol VL - 56 UR - https://doi.org/10.1136/jcp.56.5.378 DO - 10.1136/jcp.56.5.378 ID - Wang2003 ER - TY - JOUR AU - Rakha, E. A. AU - Boyce, R. W. AU - Abd El-Rehim, D. PY - 2005 DA - 2005// TI - Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer JO - Mod Pathol VL - 18 UR - https://doi.org/10.1038/modpathol.3800445 DO - 10.1038/modpathol.3800445 ID - Rakha2005 ER - TY - JOUR AU - Duncan, T. J. AU - Watson, N. F. AU - Al-Attar, A. H. PY - 2007 DA - 2007// TI - The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer JO - World J Surg Oncol VL - 5 UR - https://doi.org/10.1186/1477-7819-5-31 DO - 10.1186/1477-7819-5-31 ID - Duncan2007 ER - TY - JOUR AU - Gritti, I. AU - Banfi, G. AU - Roi, G. S. PY - 2000 DA - 2000// TI - Pepsinogens: physiology, pharmacology athophysiology and exercise JO - Pharmacol Res VL - 41 UR - https://doi.org/10.1006/phrs.1999.0586 DO - 10.1006/phrs.1999.0586 ID - Gritti2000 ER - TY - JOUR AU - Westerveld, B. D. AU - Pals, G. AU - Lamers, C. B. PY - 1987 DA - 1987// TI - Clinical significance of pepsinogen A isozymogens, serum pepsinogen A and C levels, and serum gastrin levels JO - Cancer VL - 59 UR - https://doi.org/3.0.CO;2-G DO - 3.0.CO;2-G ID - Westerveld1987 ER - TY - JOUR AU - Ichinose, M. AU - Miki, K. AU - Wong, R. N. PY - 1991 DA - 1991// TI - Methylation and expression of human pepsinogen genes in normal tissues and their alteration in stomach cancer JO - Jpn J Cancer Res VL - 82 UR - https://doi.org/10.1111/j.1349-7006.1991.tb01904.x DO - 10.1111/j.1349-7006.1991.tb01904.x ID - Ichinose1991 ER - TY - JOUR AU - Tani, Y. AU - Akiyama, Y. AU - Fukamachi, H. PY - 2007 DA - 2007// TI - Transcription factor SOX2 up-regulates stomach-specific pepsinogen A gene expression JO - J Cancer Res Clin Oncol VL - 133 UR - https://doi.org/10.1007/s00432-006-0165-x DO - 10.1007/s00432-006-0165-x ID - Tani2007 ER - TY - JOUR AU - Teasdale, C. AU - Mander, A. M. AU - Fifield, R. PY - 1977 DA - 1977// TI - Serum beta2-microglobulin in controls and cancer patients JO - Clin Chim Acta VL - 78 UR - https://doi.org/10.1016/0009-8981(77)90346-1 DO - 10.1016/0009-8981(77)90346-1 ID - Teasdale1977 ER - TY - JOUR AU - Hemmingsen, L. AU - Skaarup, P. PY - 1977 DA - 1977// TI - Urinary excretion of ten plasma proteins in patients with renal carcinoma JO - Scan J Urol Nephrol VL - 11 UR - https://doi.org/10.3109/00365597709179690 DO - 10.3109/00365597709179690 ID - Hemmingsen1977 ER - TY - JOUR AU - Shuster, J. AU - Gold, P. AU - Poulik, M. D. PY - 1976 DA - 1976// TI - beta 2-microglogulin levels in cancerous and other disease states JO - Clin Chim Acta VL - 67 UR - https://doi.org/10.1016/0009-8981(76)90339-9 DO - 10.1016/0009-8981(76)90339-9 ID - Shuster1976 ER - TY - JOUR AU - Ward, D. G. AU - Nyangoma, S. AU - Joy, H. PY - 2008 DA - 2008// TI - Proteomic profiling of urine for the detection of colon cancer JO - Proteome Sci VL - 6 UR - https://doi.org/10.1186/1477-5956-6-19 DO - 10.1186/1477-5956-6-19 ID - Ward2008 ER - TY - JOUR AU - Yang, J. AU - Qian, J. AU - Wezeman, M. PY - 2006 DA - 2006// TI - Targeting beta2-microglobulin for induction of tumor apoptosis in human hematological malignancies JO - Cancer Cell VL - 10 UR - https://doi.org/10.1016/j.ccr.2006.08.025 DO - 10.1016/j.ccr.2006.08.025 ID - Yang2006 ER - TY - JOUR AU - Abdul, M. AU - Hoosein, N. PY - 2000 DA - 2000// TI - Changes in beta-2 microglobulin expression in prostate cancer JO - Urol Oncol VL - 5 UR - https://doi.org/10.1016/S1078-1439(00)00063-6 DO - 10.1016/S1078-1439(00)00063-6 ID - Abdul2000 ER - TY - JOUR AU - Gross, M. AU - Top, I. AU - Laux, I. PY - 2007 DA - 2007// TI - Beta-2-microglobulin is an androgen-regulated secreted protein elevated in serum of patients with advanced prostate cancer JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-06-1156 DO - 10.1158/1078-0432.CCR-06-1156 ID - Gross2007 ER -